Diagnostic Solutions Laboratory
Diagnostic Solutions Laboratory was founded to bridge the gap between healthcare providers and the clinical laboratory. Our commitment is to serve the clinical needs of the health care provider with cutting-edge laboratory medicine by utilizing proven methodologies that are accurate and reliable. By working with experienced clinicians and opinion leaders throughout multiple medical disciplines we are able to build assays that are clinically relevant and provide actionable results.
Since the introduction of the GI-MAP™ (GI Microbial Assay Plus) in 2015, Diagnostic Solutions Laboratory has established itself as the leader in quantitative PCR GI testing. With a commitment to research, and by using the latest in qPCR technology, we have experienced unparalleled growth while providing our practitioners with the most sensitive, specific and diagnostically relevant GI stool testing results available.
Now, Diagnostic Solutions Laboratory is once again at the forefront of laboratory science, bringing clinicians the latest revolutionary clinical assessment tool, the CytoDx™. With an assessment of 16 key serum cytokines, the CytoDx™ provides clinicians with powerful insight into their patient’s systemic immune regulatory function, allowing for advanced health assessment and individualized treatment plans based on specific immune responses.
Join Betsy Redmond, PhD. MMSc, RD, on September 7 at 2 PM ET for an exciting webinar discussing the role metabolomic testing plays in evaluating gut health.
Metabolomics can help clinicians better identify areas of concern and reveal early… Read More
Irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) are commonly-diagnosed conditions. Yet, it is often challenging for practitioners to help patients with these conditions to achieve satisfactory, long-term symptom… Read More
Developments in Metabolomics: Dietary Insights & Impacts for Clinical Practice
Precision nutrition utilizes -omics techniques to personalize diets. Metabolomic testing plays a key role in clinical practice. It identifies current individual… Read More
Functional gastrointestinal (GI) disorders such as irritable bowel syndrome and functional dyspepsia is thought to affect at least 15% of the general population. Mast cell activation and dysbiosis are among the leading pathophysiological processes that… Read More
Join us on September 17th at 3 PM ET, as Dr. Tom Fabian presents an exciting webinar about the role the microbiome plays in food sensitivities. Adverse food reactions - including food allergies, food sensitivities, and food intolerances - are among the… Read More
Metabolomics is the study of endogenous metabolites from biological systems, identifying earlier stages of diseases, impairments in specific pathways, and responses to intrinsic and extrinsic factors. Utilizing organic acids as a tool in functional… Read More
The term “dysbiosis” denotes imbalances or disruptions in the microbiome that are thought to contribute to a long and growing list of chronic diseases and conditions. To date, microbiome research has largely focused on dysbiosis in the… Read More
Nutrigenomics is a fascinating, yet complicated, field that many healthcare practitioners are interested in utilizing to find solutions for their patients. However, with the vast amount of information available, the barrier to entry can feel quite high.… Read More